Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• Pediatric malignancy survival has improved, but high toxicities and treatment resistance remain significant challenges.
• Gene transfer presents a promising avenue for developing highly specific and effective pediatric cancer therapies.

Purpose of the Study:

• To explore the potential of gene therapy in treating childhood cancers.
• To outline various gene therapy strategies for pediatric malignancies, including genetic correction, drug sensitization, anti-angiogenesis, normal tissue protection, and immune modulation.

Main Methods:

• Review of current gene therapy approaches for pediatric cancer.
• Discussion of gene transfer mechanisms targeting cancer cells, tumor vasculature, normal tissues, and the immune system.
• Examination of preliminary Phase 1 clinical studies and their implications.

Main Results:

• Gene therapy can be applied through multiple strategies: correcting genetic abnormalities, sensitizing cancer cells to drugs, inhibiting tumor vascularization, enhancing normal tissue resistance, and modulating the immune response.
• Preliminary Phase 1 studies in pediatric cancer patients have been reported, though significant clinical success has not yet been achieved.

Conclusions:

• Gene therapy holds considerable potential for revolutionizing pediatric cancer treatment by offering targeted and personalized therapeutic options.
• Advancements in gene delivery technologies and a deeper understanding of tumor progression and immune evasion pave the way for combining gene therapy with conventional treatments for improved outcomes in childhood cancer.